Merck Sharp & Dohme LLC
Registry sponsor category
Industry
- Company name
- Merck Sharp & Dohme LLC
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Merck Sharp and Dohme LLC
- Merck Sharp & Dohme LLC
- Merck Sharp & Dohme Corporation
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (4,244)
- 'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'
- "Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
- "NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes"
- "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"
- [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)
- [18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)
- [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
- 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)
- 129 Xenon Imaging in Patients Treated With Sotatercept
- 1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
- 18F-FLT-PET in Breast Cancer (MK-0000-139)
- 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
- 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)
- 3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
- 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
- 36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8
- 4 Pillars Toolkit for Adolescent Vaccination
- 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
- 5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)
- 5-Alpha Reductase and Anabolic Effects of Testosterone